You just read:

Victoza® (liraglutide 1.8 mg) Provided Superior HbA1c Reductions in Adults with Type 2 Diabetes Compared to Continued Sitagliptin Treatment

News provided by

Novo Nordisk

02 Apr, 2016, 18:15 BST